Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics | $6.01 | $3.24 | 1.17% | 99.4M | $67.7M | $1.47$15.49 |
| KZR | Kezar Life Sciences | $6.36 | $2.19 | 0.53% | 5.9M | $30.5M | $3.53$8.45 |
| CREV | Carbon Revolution Public Limited Ordinary Shares | $5.46 | $1.74 | 46.58% | - | - | - |
| VHC | VirnetX | $23.87 | $6.87 | 0.40% | 2.2M | $72.6M | $3.68$29 |
| NUAI | New Era Energy & Digital, Inc. | $4.54 | $1.39 | 44.17% | - | - | - |
| NXTC | NextCure | $11.93 | $3.23 | 0.37% | 429.9K | $23.3M | $2.69$19.2 |
| ACHV | Achieve Life Sciences | $4.2 | $1.12 | 0.36% | 15.9M | $157.4M | $1.84$5.31 |
| SGHT | Sight Sciences | $4.69 | $1.24 | 0.36% | 1.6M | $180.7M | $2.03$6.08 |
| ELBM | Electra Battery Materials Corporation | $2.22 | $0.58 | 35.37% | - | - | - |
| ADXN | Addex Therapeutics | $10.95 | $2.42 | 0.28% | 31.5K | $7.9M | $6.51$12.05 |
Related Articles
Featured Article
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
Cory Renauer|Sep 7, 2025
Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
Keith Noonan|Aug 12, 2025
Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?
1 Reason to Buy MindMed (MNMD)
Eric Volkman|Aug 7, 2025
The U.S. public and the nation's politicians seem to be coming around to the idea of reforming psychedelic drug laws. Looser restrictions on research would help this company.
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Leo Miller|Aug 29, 2024
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher
David Jagielski|Apr 25, 2024
For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?
Alex Carchidi|Apr 20, 2023
Atai's stock is hurting, but its pipeline is still packed with promising programs.
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Alex Carchidi|Mar 17, 2023
Biotechs are capable of making huge gains in short periods, and they often do.
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic
George Budwell|Feb 9, 2023
Wall Street is bullish on these two beaten-down healthcare stocks.
Wall Street Says This Stock Can Deliver a 543% Return. Should You Listen?
Cory Renauer|Sep 15, 2022
Find out why investment bank analysts think this stock is positioned for a six-fold gain.
This Meme Stock Just Did a Huge Reverse Stock Split
David Jagielski|Sep 8, 2022
Is Mind Medicine a buy?
